Therapeutic effects of micro-RNAs in preclinical studies of acute kidney injury: a systematic review and meta-analysis
Abstract AKI has a high mortality rate, may lead to chronic kidney disease, and effective therapies are lacking. Micro-RNAs (miRNAs) regulate biologic processes by potently inhibiting protein expression, and pre-clinical studies have explored their roles in AKI. We conducted a systematic review and...
Guardado en:
Autores principales: | Sarah Zankar, Mayra Trentin-Sonoda, Jose L. Viñas, Rosendo A. Rodriguez, Adrian Bailey, David Allan, Kevin D. Burns |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/934689081d0644ea8ebe3c6a87dec35c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Urinary microRNAs as non-invasive biomarkers for toxic acute kidney injury in humans
por: Fathima Shihana, et al.
Publicado: (2021) -
Role of microRNAs in Obesity-Related Kidney Disease
por: Maite Caus, et al.
Publicado: (2021) -
Role of microRNAs in COVID-19 with implications for therapeutics
por: Nahid Arghiani, et al.
Publicado: (2021) -
Long non-coding RNAs as novel diagnostic and therapeutic targets in kidney disease
por: Qin Zhou, et al.
Publicado: (2019) -
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension
por: Hebah A. Sindi, et al.
Publicado: (2020)